Next Article in Journal
Young and Exhausted
Previous Article in Journal
Cardiology and COVID: A Bidirectional Association!
 
 
Advances in Respiratory Medicine is published by MDPI from Volume 90 Issue 4 (2022). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Via Medica.
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Letter

Risk Assessment and Prognostic Aspect of Coagulopathy in COVID-19

by
Mujibur Rahman
and
Nadira Naznin Rakhi
*
Department of Biotechnology and Genetic Engineering, Bangabandhu Sheikh Mujibur Rahman Science and Technology University, Gopalganj, Bangladesh
*
Author to whom correspondence should be addressed.
Adv. Respir. Med. 2021, 89(1), 90-91; https://doi.org/10.5603/ARM.a2020.0191
Submission received: 7 September 2020 / Revised: 29 January 2021 / Accepted: 29 January 2021 / Published: 9 July 2020

Excerpt

Note: In lieu of an abstract, this is an excerpt from the first page.

Coronavirus disease 2019 (COVID-19) primarily being considered as a respiratory illness has been showing a highly diverse and anomalous array of symptoms since its origin in December 2019 [...]

Share and Cite

MDPI and ACS Style

Rahman, M.; Rakhi, N.N. Risk Assessment and Prognostic Aspect of Coagulopathy in COVID-19. Adv. Respir. Med. 2021, 89, 90-91. https://doi.org/10.5603/ARM.a2020.0191

AMA Style

Rahman M, Rakhi NN. Risk Assessment and Prognostic Aspect of Coagulopathy in COVID-19. Advances in Respiratory Medicine. 2021; 89(1):90-91. https://doi.org/10.5603/ARM.a2020.0191

Chicago/Turabian Style

Rahman, Mujibur, and Nadira Naznin Rakhi. 2021. "Risk Assessment and Prognostic Aspect of Coagulopathy in COVID-19" Advances in Respiratory Medicine 89, no. 1: 90-91. https://doi.org/10.5603/ARM.a2020.0191

Article Metrics

Back to TopTop